Ascension® Humeral Resurfacing Arthroplasty Follow-Up Study

Study Overview
=================
Brief Summary
-----------------
It is a non-randomized, consecutive enrollment, 10-year follow-up study of patients who are treated with the Ascension® HRA. Its purpose is to measure and document the outcomes associated with implanting the Ascension HRA prosthesis. Patients will be periodically assessed to collect data related to safety and effectiveness endpoints at the following intervals: preoperative, surgery/immediate post-op, 3 months, 6 months, 1 year, 2 year, 5 year, and 10 years.

Detailed Description
-----------------
At each assessment interval, information on complications and adverse events will be collected. In addition, shoulder joint range of motion will be collected, and implants will be evaluated radiographically to determine joint position and assess implant with regards to radiolucencies, subsidence and subluxation (migration). Patient satisfaction with regard to the effect of the implant on shoulder function, joint pain, and overall satisfaction will be assessed using a visual analog scale (VAS). Furthermore, if there are any implant revisions during the 10-year follow-up for any of the patients enrolled in the study, the implant and/or surrounding tissue will be harvested if possible and submitted for histopathological examination.

Official Title
-----------------
Ascension® Humeral Resurfacing Arthroplasty Follow-Up Study

Conditions
-----------------
Shoulder Arthritis Osteoarthritis, Rheumatoid Arthritis Shoulder, Acquired Deformity of Head, Post-traumatic Arthrosis of Other Joints, Shoulder Region

Intervention / Treatment
-----------------
* Device: Ascension HRA device


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: The following patient will be included in the study - Patient who: Is treated with the Ascension HRA; Is disabled by either non-inflammatory or inflammatory arthritis (i.e. rheumatoid arthritis, osteoarthritis and avascular necrosis; Has mild or moderate humeral head deformity and /or limited motion; Has post-traumatic arthritis; Has an intact or reparable rotator cuff; Has the means and ability to return for all required study visits Is willing to participate in the study; Has signed an Informed Consent Form; Is at least 18 years of age and skeletally mature at the time of surgery; Is less than 75 years of age at the time of surgery Exclusion Criteria: The following patients will be excluded from the study - Patients who: Infection, sepsis, and osteomyelitis; Osteoporosis; Metabolic disorders which may impair bone formation; Osteomalacia; Rapid joint destruction, marked bone loss or bone resorption apparent on X-ray; Revision procedures where other devices or treatments have failed Refuses to be in the study; or does not have the means and ability to return for all required study visits; Currently participating in another clinical study.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 75 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: HRA Device<br>Patients who will be treated with Ascension HRA device. | Device: Ascension HRA device<br>* Patients who are treated with the Ascension® HRA for resurfacing of humeral head.<br>* Other names: Ascension Metal HRA device;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| American Shoulder and Elbow Surgeon Score | The ASES score will be evaluated at 2 years and compared to baseline. | Outcome data will be evaluated at 2 years | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Range of Motion | Shoulder range of motion will be measured compared to baseline. | 2 years | 
| VAS scale for pain | VAS score for pain will be evaluated at 2 years and compared to baseline. | 2 years | 
| AP and axillary radiographs | Radiographs will be evaluated at 2 years for subsidence, lucent lines and evidence of movement or pending failure. | 2 years | 
| Adverse events | AEs will be assessed at each study timepoint | 2 years and during entire trial | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Humeral Resurfacing, Humeral Resurfacing Arthroplasty